According to the results of a study presented at the 2007 San Antonio Breast Cancer Symposium, the Oncotype DX™ test may help guide chemotherapy decisions among women with node-positive, estrogen receptor-positive breast cancer....
Read More...
[Source: Breast Cancer News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment